Literature DB >> 1263112

Pharmacokinetics of acetaminophen elimination by anephric patients.

D T Lowenthal, S Oie, J C Van Stone, W A Briggs, G Levy.   

Abstract

The pharmacokinetics of acetaminophen elimination were determined in five surgically anephric and five physiologically anephric patients on an interdialysis day, and in three normal adult volunteers. There was no significant difference in the biologic half-life and no apparent difference in the volume of distribution of acetaminophen between the three groups of subjects but the anephrics, unlike the normal subjects, showed pronounced accumulation of acetaminophen glucuronide and sulfate in plasma. The apparent volume of distribution for conjugated acetaminophen is considerably smaller than that for the unmetabolized drug even though neither acetaminophen nor its glucuronide or sulfate is significantly bound to plasma proteins. The results of this study indicate that the kidneys do not contribute significantly to the elimination of acetaminophen in man. Sin ce acetaminophen is eliminated largely by conjugation with glucuronic acid and sulfate, it can be concluded that the kidneys do not contribute significantly to the formation of these metabolites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263112

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics.

Authors:  Shuyu Lin; Wenzhuo Yu; Bo Wang; Yichao Zhao; Ke En; Jialun Zhu; Xuanbing Cheng; Crystal Zhou; Haisong Lin; Zhaoqing Wang; Hannaneh Hojaiji; Christopher Yeung; Carlos Milla; Ronald W Davis; Sam Emaminejad
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

4.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Authors:  Aida Kulo; Mariska Y Peeters; Karel Allegaert; Anne Smits; Jan de Hoon; Rene Verbesselt; Liesbeth Lewi; Marc van de Velde; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

5.  Time-dependent variations in the organ extraction ratios of acetaminophen in rat.

Authors:  P M Bélanger; M Lalande; F Doré; G Labrecque
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

Review 6.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

7.  Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  Metabolism of amitriptyline in patients with chronic renal failure.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; B Hory; Y St Hillier; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

10.  Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic Model.

Authors:  Sarah F Cook; Chris Stockmann; Samira Samiee-Zafarghandy; Amber D King; Nina Deutsch; Elaine F Williams; Diana G Wilkins; Catherine M T Sherwin; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.